UniSA Ventures is the technology translation, commercialisation,
investment and intellectual property management company of
the University of South Australia (UniSA).
By identifying research with solid commercial potential, and connecting with industry to license technology or create a spin-out company, we help UniSA’s researchers share their innovations with the world.
Review invention disclosures from UniSA members and assess suitability of IP for commercialisation
Review UniSA IP and if it meets requirement for patent and commercial potential, apply for patents on behalf of inventors, UniSA and other stakeholders
Identify investors and company structure to form spin-out company, including the developing the team to run the company
Seek and engage potential industry partners to license relevant IP for translation to industry or end users for commercial and social benefit respectively
Provide advice to UniSA members on IP considerations during applications for research grants, contract research and consulting projects
Contact and attract investors on behalf of UniSA members to invest and translate IP through licensing or spin-out companies
spin-out investments
in investment secured by spin-out companies (Since 2012)
licence deals executed (Since 2012)
investment exits with proceeds returned to UniSA
invention disclosures a year
secured in grants & contract R&D by leveraging UniSA IP (Since 2012)
Unlocking the commercial potential of research requires expertise in both technology and business to bridge the gap between researchers, industry and investors.
UniSA Professor Stuart Pitson will draw on $10 million seed funding in a collaboration with Monash University to ...
Read more
Earlier this year, TTG Transportation Technology was sold to Toronto-based technology company, Modaxo, which specialises in global public ...
Read more
World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living ...
Read more
Supporting the commercialisation of UniSA software research.
Read more
2020 is off to a strong start for UniSA Ventures, with four new technologies added to our portfolio ...
Read more
A new $45 million investment fund has been launched to accelerate the development and commercialisation of health and ...
Read more
UniSA Ventures spin-out biotech company Ferronova has completed the first batch of manufacturing at UniSA’s state of the ...
Read more
Professors from UniSA will work together with GSK scientists to test GSK compound libraries against a target protein ...
Read more
Myriota today announced that former NASA astronaut and ex-DARPA Deputy Director of the Tactical Technology Office, Pamela Melroy, ...
Read more
Companies form partnership to support manufacture of over 12,000 massive mirror assemblies in South Australia for the Aurora ...
Read moreSome of these cookies are essential for the website to function correctly, while others may collect your personal information. In some cases, the personal information collected by our cookies may be shared with third party service providers.
For details about the categories of cookies that we use, and to set your cookie preferences, please select ‘More information’ before you continue. For an overview see our Privacy Statement, or review our Privacy Policy in full.